International Journal of Nephrology / 2017 / Article / Tab 3

Clinical Study

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 3

Serum albumin-corrected calcium, P, and whole-PTH levels during the denosumab treatment course.

Baseline1 week1 month value

Corrected Ca (mg/dl)9.2 ± 0.58.5 ± 1.19.2 ± 0.9
Phosphate (mg/dl)5.0 ± 1.34.2 ± 0.94.0 ± 1.1
W-PTH (pg/dl)164 (58.5 to 228)224 (96 to 355.5)161 (82.5 to 234)NS

W-PTH: whole PTH. Median and interquartile range are shown for whole PTH.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.